Navigation Links
Asenapine Meets Primary Endpoint in Long-Term Schizophrenia Relapse Prevention Trial
Date:10/23/2008

rough its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to Earn Trust, Every Day with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com.

SCHERING-PLOUGH DISCLOSURE NOTICE: The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the plans for, the potential of and the potential market for asenapine. Forward-looking statements relate to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough's forward-looking statements, including the regulatory process, among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including the company's 8-K filed Oct. 21, 2008.


'/>"/>
SOURCE Schering-Plough
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Organons Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder
2. World Think Tank on Type 1 Diabetes Meets in Miami
3. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
4. Axial Biotech Meets Major Scientific Milestones; Receives $6 Million Tranche of Series B Financing
5. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
6. Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients
7. The Science of Music Meets the Art of Medicine - ARIMM 3rd Annual Conference at IPFW, September 12-13, 2008
8. Teliks Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
9. Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo
10. OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer
11. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Vivakor, Inc. (OTC Bulle...ders of record on December 1, 2009 will receive th...ica, Inc. that was previously approved by Vivakor,...Nevada corporation of which Vivakor owned approxim...record date. The distribution date is still expect...
(Date:12/3/2009)...swire/ -- JourneyLite of Houston, LLC announced ...tients a second surgical option, vertical sleeve ...m that it currently performs. The first sleeve ga...by surgeon partner, Matthew St. Laurent, MD on O...well. ,, The Vertical Sleeve Gastrectomy (also ...
(Date:12/3/2009)...wswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: ...ompany, today announced a voluntary recall of five...f the Attention-Deficit/Hyperactivity Disorder (AD...ction because some Daytrana patches do not meet or...moval specification, and as a result, patients and...
(Date:12/3/2009)...a, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.... Biotechnology Co. Ltd.,( http://www.beikebiotech....c,Foot Care in New Delhi, India, November 22, 2009...regenerative medicine company. , The conf...on (IPA), aimed,to help podiatrists and researcher...
Breaking Biology Technology:Vivakor Confirms Record Date of Stock Dividend 2Vivakor Confirms Record Date of Stock Dividend 3JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3
..., Wis. - Space Place , the University of Wiscons...ving to a new location at Villager Mall, opening S...hrough Thursday, Sept. 1 and are free and open to ...ther place where we,d been for 15 years," said dir... has increased steadily every year, and our ambiti...
..., Wis. - The life sciences company Promega announ...with Australian firm Benitec that had been pending...der the terms of the settlement, Promega will hold... make and sell research products based around Beni...ology. Promega will also receive a combined paymen...
...of business investors and government representativ... Act 255 that was enacted to stimulate investments...ere made to a state Senate committee on Wednesday....ill stymie business investment in high-growth comp...ecommendations: , , Increasing from $30 million to...
Other Biology Technology:Space Place opens new astronomy center 2Suggestions offered to foster high-growth business investment 2
(Date:12/4/2009)...skovar, a Texas AgriLife Research plant physiologi...nter in Uvalde, has been investigating ways to hel...n from the greenhouse to the field. , "This rese...ibly even the further profitability of some vegeta... plants that will establish well," Leskovar said. ...
(Date:12/4/2009)...lable in German . , A new study of the Max Pl... understand the positive effect of dietary restric...ferent organisms (fruit flies and mice) have shown... with a potential negative side effect of diminish...ess frequently with a reduced litter size on a low...
(Date:12/3/2009)...n new information and adapt to changes in our dail...ies, appears to lie in the minute junctions where ...by NYU Langone Medicine Center researchers. The st...Nature . , The scientists, led by Wen-Biao Gan,...cience at NYU School of Medicine, discovered that ...
Breaking Biology News(10 mins):Texas AgriLife researchers helping 2Texas AgriLife researchers helping 3Texas AgriLife researchers helping 4How nutrition affects healthy aging 2Lifelong memories linked to stable nerve connections 2Profiles International Finds High Employee Utilization is One Key to Maximizing Productivity 58447 1Profiles International Finds High Employee Utilization is One Key to Maximizing Productivity 58447 2Profiles International Finds High Employee Utilization is One Key to Maximizing Productivity 58447 3New Online Continuing Education Course on Near Death Experience Added to HealthForumOnline 26apos 3Bs Library for Mental Health Professionals 58442 1New Online Continuing Education Course on Near Death Experience Added to HealthForumOnline 26apos 3Bs Library for Mental Health Professionals 58442 2New Online Continuing Education Course on Near Death Experience Added to HealthForumOnline 26apos 3Bs Library for Mental Health Professionals 58442 3New Online Continuing Education Course on Near Death Experience Added to HealthForumOnline 26apos 3Bs Library for Mental Health Professionals 58442 4New Online Continuing Education Course on Near Death Experience Added to HealthForumOnline 26apos 3Bs Library for Mental Health Professionals 58442 5Paul Marks prize recognizes 3 young cancer researchers 58437 1Paul Marks prize recognizes 3 young cancer researchers 58437 2Paul Marks prize recognizes 3 young cancer researchers 58437 3Paul Marks prize recognizes 3 young cancer researchers 58437 4Paul Marks prize recognizes 3 young cancer researchers 58437 5
...serious suicide attempts or death by suicide gener...aking antidepressant medication, according to a ne...s and published in the January issue of The Americ...t the risk of suicidal behavior after starting 10 ...risk posed by older medications. , These findings...
...l rate of incidence and mortality-the number of th...om it-Glioblastoma Multiforme (GBM) is a brain can...people who are diagnosed with GBM annually in the ...thin 3 years. Currently, the only treatments that ... surgeries to remove the tumor and radiation treat...
...have developed a method to engineer blood vessels ...uscle. Trials have resulted in significant improv...n the journal Artificial Organs. , With heart di...uting to increasing mortality rates, there has bee... the specific challenges in the field of tissue en...
Other Biology News:Suicide risk does not increase when adults start using antidepressants, study finds 2Radiotherapy advance points way to noninvasive brain cancer treatment 2Radiotherapy advance points way to noninvasive brain cancer treatment 3
Mouse IgM EIA Kit from Assay Designs/Stressgen Bioreagents
Custom Human Cytokine Antibody Array, Choose from hundreds of proteins. from Raybiotech, Inc.
Goat Anti-Mouse Ig + IgM Antibody, FITC Conjugated from Cayman Chemical
CopyControl Induction Solution from EPICENTRE Biotechnologies
Biology Products: